ストックスクリーナーアプリを入手
4.68
2.30%
-0.11
アフターアワーズ：
4.67
-0.010
-0.21%
Rxsight Inc (RXST) 最新ニュース
RxSight, Inc. Hits 52-Week Low of $4.58 Amidst 92.2% Decline - MarketsMojo
RxSight, Inc. Stock Plummets to New 52-Week Low of $4.49 - Markets Mojo
RxSight, Inc. (RXST) Reports Q3 Loss, Tops Revenue Estimates - MSN
RxSight Inc. (RXST) Falters Near Support: Testing Key Levels After 1.96% DeclineDark Pool Sentiment - newsline.com
Understanding Momentum Shifts in (RXST) - Stock Traders Daily
RxSight, Inc. Hits 52-Week Low at $5.31 Amid Ongoing Struggles - MarketsMojo
RxSight, Inc. Hits 52-Week Low at USD 4.93 Amidst Ongoing Struggles - MarketsMojo
RxSight Inc. (RXST) Slides 3% as Stock Struggles Below Key Resistance at $5.03Hedge Fund Exposure - newsline.com
RxSight Inc. (RXST) Q1 2026 Earnings: EPS Miss Weighs on Shares Amid Operating ChallengesProfitability Analysis - newsline.com
RXST Technical Analysis & Stock Price Forecast - Intellectia AI
RxSight Inc stock (US78419L1008): Nasdaq-listed eye-care specialist in focus after recent price weak - AD HOC NEWS
RXST Q1 2026 Earnings: EPS Misses Estimates by a Wide Margin; Stock DeclinesEarnings Call Highlights - newsline.com
RxSight Inc. (RXST) Slips 4.65% as Stock Challenges $5.06 Support LevelTICK Divergence - The Legal Advocate
RxSight Securities Lawsuit Advances After Court Denies Dismissal Bid - TipRanks
RXST Q1 2026 Earnings: EPS Misses Estimates Amid Ongoing Ramp-UpEPS Growth Rate - The Legal Advocate
Midday Stock Roundup: TTM Drops on Investor Day - Orange County Business Journal
RxSight Must Litigate Investor Suit Over Eye Lens System Demand - Bloomberg Law News
RXST: Premium IOL penetration grows as competitive headwinds ease and commercial focus intensifies - TradingView
Avoiding Lag: Real-Time Signals in (RXST) Movement - Stock Traders Daily
RxSight Inc. Q1 2026 Earnings: EPS Misses Estimates Amid Operational HeadwindsOne-Time Loss Impact - Newser
RxSight Q1 2026 Earnings: EPS Misses Estimates by 32% as Operational Costs WeighEarnings Beat Streak - The Legal Advocate
RxSight stock gains ahead of Stifel meeting, investors wait for signs of turnaround - Bez Kabli
RxSight to present at Stifel 2026 Virtual Ophthalmology Forum on May 26 - Pluang
RxSight, Inc. to Present at the Stifel 2026 Virtual Ophthalmology Forum - The Manila Times
RxSight stock (US78419L1008): Q1 revenue dip and share slide put growth story to the test - AD HOC NEWS
Tarsus, RxSight Fall Despite Growth Signals - Orange County Business Journal
RxSight stock (US78419L1008): FDA-linked growth and execution stay in focus - AD HOC NEWS
RxSight stock (US78419L1008): FDA-backed growth story stays in focus - AD HOC NEWS
Number of shareholders of RxSight, Inc. – NASDAQ:RXST - TradingView
Discipline and Rules-Based Execution in RXST Response - Stock Traders Daily
RxSight Earnings Call Balances Growth With Headwinds - TipRanks
TradingKey - TradingKey
BofA Securities Maintains RxSight(RXST.US) With Sell Rating - Moomoo
RXST: Stable Q1 results and ongoing commercial initiatives support sequential growth and global expansion - TradingView
Artisan Partners reports 5.0% stake in RxSight (NASDAQ: RXST) - Stock Titan
Midday Stock Roundup: Skyworks Solutions Falls - Orange County Business Journal
RxSight (RXST) Q1 2026 Earnings Transcript - AOL.com
RxSight, Inc. (NASDAQ:RXST) Q1 2026 Earnings Call Transcript - Insider Monkey
RxSight (RXST) Gets a Hold from Stifel Nicolaus - The Globe and Mail
William Blair Maintains RxSight(RXST.US) With Hold Rating - Moomoo
RxSight, Inc. Reports First Quarter 2026 Results and Reiterates Full-Year Sales Outlook - VisionMonday.com
Piper Sandler Maintains RxSight(RXST.US) With Hold Rating, Maintains Target Price $10 - Moomoo
RxSight, Inc. Q1 2026 Earnings Call Summary - Yahoo Finance
1.21%
1.43%
大文字化:
|
ボリューム (24 時間):